Cidara Therapeutics, Inc. Quarterly Return On Equity in % from Q3 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cidara Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2015 to Q3 2024.
  • Cidara Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -219 %, a 105% decline year-over-year.
  • Cidara Therapeutics, Inc. annual Return On Equity for 2023 was -2.68K %, a 877% decline from 2022.
  • Cidara Therapeutics, Inc. annual Return On Equity for 2022 was 345 %.
  • Cidara Therapeutics, Inc. annual Return On Equity for 2021 was -573 %, a 169% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -219 -4.96K -105% Jul 1, 2024 Sep 30, 2024
Q2 2024 -460 +4.29K +90.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 492 +252 +105% Jan 1, 2024 Mar 31, 2024
Q4 2023 -2.68K -3.03K -877% Oct 1, 2023 Dec 31, 2023
Q3 2023 4.75K +3.45K +267% Jul 1, 2023 Sep 30, 2023
Q2 2023 -4.75K -7.43K -277% Apr 1, 2023 Jun 30, 2023
Q1 2023 240 +950 Jan 1, 2023 Mar 31, 2023
Q4 2022 345 +918 Oct 1, 2022 Dec 31, 2022
Q3 2022 1.29K +1.99K Jul 1, 2022 Sep 30, 2022
Q2 2022 2.68K +3.01K Apr 1, 2022 Jun 30, 2022
Q1 2022 -710 -347 -95.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -573 -360 -169% Oct 1, 2021 Dec 31, 2021
Q3 2021 -695 -536 -337% Jul 1, 2021 Sep 30, 2021
Q2 2021 -323 -227 -236% Apr 1, 2021 Jun 30, 2021
Q1 2021 -363 -273 -301% Jan 1, 2021 Mar 31, 2021
Q4 2020 -213 -112 -111% Oct 1, 2020 Dec 31, 2020
Q3 2020 -159 -73 -85.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -96.4 +13.2 +12% Apr 1, 2020 Jun 30, 2020
Q1 2020 -90.7 +1.57 +1.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -101 -11.1 -12.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -85.8 +5.71 +6.24% Jul 1, 2019 Sep 30, 2019
Q2 2019 -110 -13 -13.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -92.3 +14 +13.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -90.1 -0.02 -0.02% Oct 1, 2018 Dec 31, 2018
Q3 2018 -91.5 -9.34 -11.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -96.5 -20.8 -27.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -106 -42.1 -65.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -90 -33.7 -59.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -82.2 -33.4 -68.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -75.7 -34.8 -84.9% Apr 1, 2017 Jun 30, 2017
Q1 2017 -64.1 -31.5 -96.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -56.3 -16.1 -39.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -48.8 +3.96 +7.51% Jul 1, 2016 Sep 30, 2016
Q2 2016 -41 Apr 1, 2016 Jun 30, 2016
Q1 2016 -32.6 Jan 1, 2016 Mar 31, 2016
Q4 2015 -40.3 Oct 1, 2015 Dec 31, 2015
Q3 2015 -52.8 Jul 1, 2015 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.